Ginkgo Bioworks Holdings, Inc.

DNA · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.6B · 485 employees
51
SEC Filings
$9.46
Close 2026-05-28
485
Employees

Business Summary

PART I . Unless the context otherwise requires, all references in this section to the Company, Ginkgo, we, us, or our refer to the business of Ginkgo Bioworks Holdings, Inc. and our subsidiaries. Overview: Our Mission is to Make Biology Easier to Engineer Our mission is to make biology easier to engineer. That has never changed. Every choice weve made with respect to our business model, our platform, our people, and our culture is grounded in whether it will advance our mission. Why? Because: 1....

Latest Stock Quote

DNA 2026-05-28 $9.46 O:$8.8 H:$9.65 L:$8.75 Vol:1.5M VWAP:$9.3848
origin leaf: c20438bd2c5cb3f3a4f74a3e1985bf6031438dc3ebee7d71e72ce0f6295ee491

Next Earnings

Q2 FY2026 — expected 2026-09-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012346EDGAR92K words
2025-02-252024-12-310001628280-25-007819EDGAR—
2024-02-292023-12-310001628280-24-008052EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-050193EDGAR25K words
2025-08-072025-06-300001628280-25-038982EDGAR—
2025-05-062025-03-310001628280-25-022761EDGAR—
2024-11-122024-09-300001628280-24-047284EDGAR—
2024-08-082024-06-300001628280-24-036231EDGAR—
2024-05-092024-03-310001628280-24-022229EDGAR—
2023-11-082023-09-300001628280-23-037927EDGAR—
2023-08-092023-06-300000950170-23-040721EDGAR—
2023-05-102023-03-310000950170-23-020535EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001628280-26-012552EDGAR40K words
2026-02-260001628280-26-012339EDGAR—
2025-12-230001628280-25-058791EDGAR—
2025-11-060001830214-25-000013EDGAR—
2025-09-040001830214-25-000009EDGAR—
2025-08-290001628280-25-041399EDGAR—
2025-08-070001628280-25-038981EDGAR—
2025-06-130001628280-25-031304EDGAR—
2025-05-210001628280-25-027058EDGAR—
2025-05-060001628280-25-022759EDGAR—

51 total filings indexed. 29 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001830214
TickerDNA
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.ginkgobioworks.com
Listed2021-04-19

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 65ad5a4e6cbfd3b8084873dd5de589874bf510593b90a389b6749463cec9cba6
parent: 322c6dd7b3a74b28bf3bac1e632e3a6e7ee205350fb5bf074acdb747b5b053a9
content hash: c409da19a00fc0d85813439e9dd24e1b64ffc5c9b1c7c16c3ba4f72e5164886a
signed: 2026-06-02T19:00:53.336Z
sources: 13 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf